Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05722951
Status:
UNKNOWN
Last Update Posted:
2023-02-10
First Post:
2023-02-01
Brief Title:
Metformin Efficacy and Safety in Epileptic Patients
Sponsor:
Tanta University
Organization:
Tanta University
Study Overview
Official Title:
Metformin Efficacy and Safety in Epileptic Patients
Status:
UNKNOWN
Status Verified Date:
2022-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to Evaluating Metformin Efficacy and Safety when Co-administered with Antiepileptic Drugs in Patients with Seizures The main question it aims to answer is
Does metformin have beneficial effect on epileptic patients
How metformin can affect epileptic patients health
Participants will be divided into 2 groups control group and treatment group
Control group will receive standard treatment levetiracetam
Treatment group will receive standard treatment levetiracetam metformin
Does metformin have beneficial effect on epileptic patients
How metformin can affect epileptic patients health
Participants will be divided into 2 groups control group and treatment group
Control group will receive standard treatment levetiracetam
Treatment group will receive standard treatment levetiracetam metformin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None